Bank of New York Mellon’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,178
| Closed | -$112K | – | 4232 |
|
|
2025
Q1 | $112K | Hold |
12,178
| – | – | ﹤0.01% | 3987 |
|
|
2024
Q4 | $81.3K | Sell |
12,178
-1
| -0% | -$9 | ﹤0.01% | 4048 |
|
|
2024
Q3 | $122K | Hold |
12,179
| – | – | ﹤0.01% | 3990 |
|
|
2024
Q2 | $190K | Sell |
12,179
-11,597
| -49% | -$194K | ﹤0.01% | 3950 |
|
|
2024
Q1 | $521K | Sell |
23,776
-1,838
| -7% | -$40.8K | ﹤0.01% | 3504 |
|
|
2023
Q4 | $496K | Sell |
25,614
-452
| -2% | -$8.25K | ﹤0.01% | 3556 |
|
|
2023
Q3 | $481K | Buy |
26,066
+10,879
| +72% | +$196K | ﹤0.01% | 3563 |
|
|
2023
Q2 | $280K | Buy |
15,187
+11,630
| +327% | +$275K | ﹤0.01% | 3865 |
|
|
2023
Q1 | $103K | Sell |
3,557
-167
| -4% | -$4.45K | ﹤0.01% | 4070 |
|
|
2022
Q4 | $103K | Sell |
3,724
-359
| -9% | -$13.6K | ﹤0.01% | 4108 |
|
|
2022
Q3 | $224K | Sell |
4,083
-369
| -8% | -$20.3K | ﹤0.01% | 3970 |
|
|
2022
Q2 | $244K | Buy |
4,452
+685
| +18% | +$25.2K | ﹤0.01% | 3980 |
|
|
2022
Q1 | $140K | Sell |
3,767
-118
| -3% | -$4.21K | ﹤0.01% | 4334 |
|
|
2021
Q4 | $95K | Sell |
3,885
-281
| -7% | -$9.41K | ﹤0.01% | 4406 |
|
|
2021
Q3 | $187K | Sell |
4,166
-11
| -0.3% | -$461 | ﹤0.01% | 4233 |
|
|
2021
Q2 | $195K | Sell |
4,177
-4,951
| -54% | -$253K | ﹤0.01% | 4106 |
|
|
2021
Q1 | $504K | Sell |
9,128
-87
| -0.9% | -$5.29K | ﹤0.01% | 3685 |
|
|
2020
Q4 | $572K | Sell |
9,215
-410
| -4% | -$25.1K | ﹤0.01% | 3555 |
|
|
2020
Q3 | $563K | Buy |
9,625
+61
| +0.6% | +$4.52K | ﹤0.01% | 3435 |
|
|
2020
Q2 | $1.07M | Sell |
9,564
-1,099
| -10% | -$78.2K | ﹤0.01% | 3074 |
|
|
2020
Q1 | $718K | Buy |
10,663
+183
| +2% | +$18.4K | ﹤0.01% | 3192 |
|
|
2019
Q4 | $1.45M | Buy |
10,480
+331
| +3% | +$42.9K | ﹤0.01% | 3035 |
|
|
2019
Q3 | $1.06M | Sell |
10,149
-243
| -2% | -$24.3K | ﹤0.01% | 3144 |
|
|
2019
Q2 | $1.1M | Buy |
10,392
+635
| +7% | +$83.7K | ﹤0.01% | 3146 |
|
|
2019
Q1 | $1.51M | Sell |
9,757
-197
| -2% | -$22.8K | ﹤0.01% | 2931 |
|
|
2018
Q4 | $926K | Sell |
9,954
-4,100
| -29% | -$586K | ﹤0.01% | 3151 |
|
|
2018
Q3 | $2.62M | Buy |
14,054
+2,168
| +18% | +$618K | ﹤0.01% | 2708 |
|
|
2018
Q2 | $4.99M | Buy |
11,886
+10,857
| +1,055% | +$3.66M | ﹤0.01% | 2392 |
|
|
2018
Q1 | $309K | Buy |
+1,029
| New | +$285K | ﹤0.01% | 3788 |
|
Bank of New York Mellon's OPTN Position: Q2 2025 in Review
Bank of New York Mellon sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 12,178 shares — an estimated $112K sold.
Bank of New York Mellon first reported a position in OPTN in Q1 2018 and held it in 29 quarters. The position peaked at $4.99M in Q2 2018. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.
- Bank of New York Mellon reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
- Bank of New York Mellon sold 12,178 OptiNose shares in Q2 2025, an estimated $112K.
- Bank of New York Mellon first reported a position in OptiNose in Q1 2018 and held it in 29 quarters.
- Bank of New York Mellon's OptiNose position peaked at $4.99M in Q2 2018.
- 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.
Based on Bank of New York Mellon's 13F filing for Q2 2025, filed 5 Aug 2025.